Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |